Core Laboratories Nv Stock Current Liabilities

CLB Stock  USD 15.00  0.60  3.85%   
Core Laboratories NV fundamentals help investors to digest information that contributes to Core Laboratories' financial success or failures. It also enables traders to predict the movement of Core Stock. The fundamental analysis module provides a way to measure Core Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Core Laboratories stock.
Short Long Term Debt TotalTotal Assets
At present, Core Laboratories' Total Current Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Non Current Liabilities Total is expected to grow to about 267 M, whereas Non Current Liabilities Other is forecasted to decline to about 19.7 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Core Laboratories NV Company Current Liabilities Analysis

Core Laboratories' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Current Liabilities

 = 

Payables

+

Accrued Debt

More About Current Liabilities | All Equity Analysis

Current Core Laboratories Current Liabilities

    
  120.76 M  
Most of Core Laboratories' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Core Laboratories NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Core Current Liabilities Driver Correlations

Understanding the fundamental principles of building solid financial models for Core Laboratories is extremely important. It helps to project a fair market value of Core Stock properly, considering its historical fundamentals such as Current Liabilities. Since Core Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Core Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Core Laboratories' interrelated accounts and indicators.
0.40.770.510.70.730.880.550.340.410.50.620.470.440.33-0.33-0.440.380.280.350.050.17-0.230.170.10.0
0.4-0.130.150.530.30.010.34-0.10.080.17-0.290.190.180.030.250.340.57-0.550.29-0.630.26-0.08-0.050.32-0.12
0.77-0.130.320.30.490.960.540.40.560.540.910.230.40.41-0.46-0.720.060.740.090.47-0.02-0.440.22-0.210.27
0.510.150.320.770.940.50.6-0.160.190.390.510.080.450.42-0.86-0.39-0.210.4-0.180.44-0.6-0.10.28-0.030.14
0.70.530.30.770.890.520.66-0.130.090.550.350.250.550.31-0.49-0.240.020.070.060.1-0.24-0.060.040.10.12
0.730.30.490.940.890.670.7-0.050.220.480.590.230.520.41-0.76-0.43-0.080.37-0.020.37-0.4-0.130.230.050.09
0.880.010.960.50.520.670.630.390.520.630.90.280.520.46-0.55-0.740.080.670.10.42-0.09-0.370.21-0.180.28
0.550.340.540.60.660.70.63-0.130.430.80.560.030.690.49-0.65-0.56-0.130.43-0.170.35-0.49-0.380.18-0.270.5
0.34-0.10.4-0.16-0.13-0.050.39-0.130.12-0.010.30.36-0.010.030.07-0.310.370.140.43-0.050.460.02-0.150.05-0.07
0.410.080.560.190.090.220.520.430.120.460.54-0.270.540.81-0.25-0.430.230.57-0.280.11-0.23-0.820.62-0.10.47
0.50.170.540.390.550.480.630.8-0.010.460.54-0.070.760.5-0.47-0.64-0.040.4-0.270.22-0.45-0.37-0.02-0.590.8
0.62-0.290.910.510.350.590.90.560.30.540.540.00.530.59-0.7-0.83-0.240.91-0.190.7-0.35-0.460.3-0.240.39
0.470.190.230.080.250.230.280.030.36-0.27-0.070.0-0.25-0.43-0.01-0.070.31-0.210.9-0.040.530.62-0.380.35-0.45
0.440.180.40.450.550.520.520.69-0.010.540.760.53-0.250.83-0.46-0.67-0.170.43-0.420.22-0.51-0.490.44-0.180.55
0.330.030.410.420.310.410.460.490.030.810.50.59-0.430.83-0.46-0.59-0.120.62-0.50.28-0.52-0.740.68-0.020.51
-0.330.25-0.46-0.86-0.49-0.76-0.55-0.650.07-0.25-0.47-0.7-0.01-0.46-0.460.650.47-0.710.29-0.770.750.14-0.250.27-0.36
-0.440.34-0.72-0.39-0.24-0.43-0.74-0.56-0.31-0.43-0.64-0.83-0.07-0.67-0.590.650.32-0.780.17-0.640.420.21-0.210.33-0.51
0.380.570.06-0.210.02-0.080.08-0.130.370.23-0.04-0.240.31-0.17-0.120.470.32-0.440.48-0.760.65-0.09-0.030.19-0.21
0.28-0.550.740.40.070.370.670.430.140.570.40.91-0.210.430.62-0.71-0.78-0.44-0.390.83-0.52-0.510.41-0.280.45
0.350.290.09-0.180.06-0.020.1-0.170.43-0.28-0.27-0.190.9-0.42-0.50.290.170.48-0.39-0.30.770.53-0.40.48-0.55
0.05-0.630.470.440.10.370.420.35-0.050.110.220.7-0.040.220.28-0.77-0.64-0.760.83-0.3-0.6-0.070.11-0.230.28
0.170.26-0.02-0.6-0.24-0.4-0.09-0.490.46-0.23-0.45-0.350.53-0.51-0.520.750.420.65-0.520.77-0.60.27-0.260.47-0.62
-0.23-0.08-0.44-0.1-0.06-0.13-0.37-0.380.02-0.82-0.37-0.460.62-0.49-0.740.140.21-0.09-0.510.53-0.070.27-0.640.18-0.44
0.17-0.050.220.280.040.230.210.18-0.150.62-0.020.3-0.380.440.68-0.25-0.21-0.030.41-0.40.11-0.26-0.640.22-0.09
0.10.32-0.21-0.030.10.05-0.18-0.270.05-0.1-0.59-0.240.35-0.18-0.020.270.330.19-0.280.48-0.230.470.180.22-0.72
0.0-0.120.270.140.120.090.280.5-0.070.470.80.39-0.450.550.51-0.36-0.51-0.210.45-0.550.28-0.62-0.44-0.09-0.72
Click cells to compare fundamentals

Core Current Liabilities Historical Pattern

Today, most investors in Core Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Core Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Core Laboratories current liabilities as a starting point in their analysis.
   Core Laboratories Current Liabilities   
       Timeline  
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition

Core Total Current Liabilities

Total Current Liabilities

100.82 Million

At present, Core Laboratories' Total Current Liabilities is projected to decrease significantly based on the last few years of reporting.
In accordance with the recently published financial statements, Core Laboratories NV has a Current Liabilities of 120.76 M. This is 98.37% lower than that of the Energy Equipment & Services sector and 89.26% lower than that of the Energy industry. The current liabilities for all United States stocks is 98.47% higher than that of the company.

Core Current Liabilities Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Core Laboratories' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Core Laboratories could also be used in its relative valuation, which is a method of valuing Core Laboratories by comparing valuation metrics of similar companies.
120.8M445.0M307.0M4.2B100%
Core Laboratories is currently under evaluation in current liabilities category among its peers.

Core Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Core Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Core Laboratories' managers, analysts, and investors.
61.7%
Environmental
Governance
Social

Core Fundamentals

Return On Equity0.13
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-4,000%-3,000%-2,000%-1,000%0%1,000%2,000%
Return On Asset0.0553
Profit Margin0.06 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-400%-200%0%200%
Operating Margin0.08 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%50%100%150%
Current Valuation863.39 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%
Shares Outstanding46.83 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-315%10%15%20%
Shares Owned By Insiders1.78 %
Shares Owned By Institutions98.22 %
Number Of Shares Shorted6.07 M
Price To Earning101.74 X
Price To Book2.79 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-5,000%-4,000%-3,000%-2,000%-1,000%0%1,000%
Price To Sales1.33 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%
Revenue523.85 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%1,200%
Gross Profit103.33 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%
EBITDA73.51 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-500%0%500%1,000%1,500%2,000%2,500%
Net Income32.15 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-2,000%0%2,000%4,000%6,000%
Cash And Equivalents15.43 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-20%-10%0%10%20%
Cash Per Share0.29 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31100%200%300%400%
Total Debt180.14 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%
Debt To Equity1.29 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-4,000%-3,000%-2,000%-1,000%0%1,000%
Current Ratio2.23 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Book Value Per Share5.38 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%0%100%200%300%400%500%
Cash Flow From Operations56.39 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%2,500%3,000%3,500%
Short Ratio18.75 X
Earnings Per Share0.66 X
Price To Earnings To Growth1.67 X
Target Price19.33
Number Of Employees3.5 K
Beta2.38
Market Capitalization698.19 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-311,000%2,000%3,000%4,000%
Total Asset590.41 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
Retained Earnings150.28 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%
Working Capital129.02 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset238.55 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%200%400%600%
Current Liabilities120.76 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%
Annual Yield0 %
Five Year Return2.66 %
Net Asset590.41 M
Last Dividend Paid0.04

About Core Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Core Laboratories NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Core Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Core Laboratories NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Core Laboratories Piotroski F Score and Core Laboratories Altman Z Score analysis.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.896
Dividend Share
0.04
Earnings Share
0.66
Revenue Per Share
11.17
Quarterly Revenue Growth
0.008
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.


 
News Freq…Investor S…